This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
We anticipate a shortfall of £1.5 million in our funding programme this year to resume current research and support vital new projects. This could have a catastrophic knock-on effect for stroke research and delay access to important new life-changing treatments that allow people to rebuild their lives after stroke.
Pain in the shoulder is a common problem after stroke. As well as causing distress through pain and lost sleep, it prevents rehabilitation of the arm and hand. This study will identify ‘who’, ‘when’ and ‘how’ to treat people with painful shoulders after stroke more effectively, and should lead to better outcomes for them.
In this study, we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
The ReTrain study is investigating the effectiveness of a community-based rehabilitation training programme for people who have suffered a stroke. Published in the journal BMJ Open, the 'study protocol' for ReTrain outlines why the study was needed, and includes the methods to be used in the study, the resources required for the study and a timeline for completion.
Visual field loss is a commonly reported side effect of stroke and can seriously impact on functional ability and quality of life. Published today in the journal, Neuro-Ophthalmology, a new study shares insights learned from recruitment of study participants to the 'VISION' trial, and how this may inform future, similar trials.
Vision problems are common after stroke. This Lectureship will investigate the link between the tasks used in vision rehabilitation and everyday visual activities. It will also use brain scanning to investigate the effects of rehabilitation on activity in the areas of the brain responsible for vision.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take homes from our International Development Officer, Sarah Belson.
Medical research is essential to develop new treatments and therapies for stroke so that patients in the UK can get the best possible care. Clinical trials are conducted to test whether a new medical intervention is safe and effective and these trials often rely on the participation of volunteer stroke survivors.